DVL
(from the thread)
Growth at +33% CAGR last three years is pretty good.
Revenue this year should be +$2.5m based on existing accounts.
BUT it's the horizon 2 customers that will drive price momentum.
$12m market cap compared to peers just doesn't stack up.
Should see this move towards 8c very soon.
The Medtronic trial is a MASSIVE achievement - they provide access to 1,000's of clinics globally.
The market will catch on, accumulate at these prices.
- Forums
- ASX - Day Trading
- Morning trading December 18
Morning trading December 18, page-251
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
BM8
BATTERY AGE MINERALS LTD
Nigel Broomham, CEO
Nigel Broomham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online